Metabolic and cardiovascular adverse effects associated with treatment with antipsychotic drugs

Medicine and Dentistry

• Cardiovascular System 100%
• Adverse Event 100%
• Typical Antipsychotic 100%
• Cardiovascular Disease 37%
• Drug Therapy 37%
• Water-Electrolyte Imbalance 25%
• Lifestyle Modification 25%
• 5-HT Receptors 25%
• Cardiovascular Effect 12%
• Side Effect 12%
• Binding Affinity 12%
• Cardiovascular Risk 12%
• Metabolic Syndrome 12%
• Maturity Onset Diabetes of the Young 12%
• Receptor Affinity 12%
• Healthy Lifestyle 12%
• Psychiatrist 12%
• Olanzapine 12%
• Receptor Binding 12%
• Glycon 12%
• Clozapine 12%
• Severe Mental Illness 12%
• Amisulpride 12%
• Ziprasidone 12%
• Quetiapine 12%
• Histamine 12%
• Serotonin 12%
• Adrenergic Receptor 12%
• Neurotransmitter Receptor 12%
• Risperidone 12%
• Amantadine 12%
• Topiramate 12%
• Aripiprazole 12%

Neuroscience

• Adverse Effect 100%
• Typical Antipsychotic 100%
• Antipsychotic 62%
• Dementia Praecox 25%
• Binding Affinity 12%
• Serotonin 12%
• Receptor Binding 12%
• Amantadine 12%
• Olanzapine 12%
• Risperidone 12%
• Amisulpride 12%
• Aripiprazole 12%
• Severe Mental Illness 12%
• Clozapine 12%
• Histamine 12%
• Topiramate 12%
• Metformin 12%
• Ziprasidone 12%
• Receptor Affinity 12%
• Quetiapine 12%
• Diabetes Mellitus 12%
• Neurotransmitter Receptor 12%
• Adrenergic Receptor 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 100%
• Antipsychotic 100%
• Typical Antipsychotic 100%
• Cardiovascular Disease 25%
• Metabolic Disorder 16%
• Metabolic Syndrome X 8%
• Cardiovascular Risk 8%
• Side Effect 8%
• Adrenergic Receptor 8%
• Non Insulin Dependent Diabetes Mellitus 8%
• Receptor 8%
• Olanzapine 8%
• Quetiapine 8%
• Risperidone 8%
• Clozapine 8%
• Amisulpride 8%
• Aripiprazole 8%
• Metformin 8%
• Amantadine 8%
• Ziprasidone 8%
• Disease 8%
• Histamine 8%
• Serotonin 8%
• Neurotransmitter Receptor 8%
• Topiramate 8%